These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 11275937

  • 21. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C, Batisse A, Collet JP, Batisse JP, Choussat R, Beygui F, Helft G, Montalescot G, Metzger JP.
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
    [Abstract] [Full Text] [Related]

  • 22. Incidence of ventricular fibrillation during left coronary arteriography in pigs: comparison of a solution of the nonionic dimer iodixanol with solutions of five different nonionic monomers.
    Chai CM, Karlsson JO, Almén T.
    Acta Radiol; 2008 Mar; 49(2):150-6. PubMed ID: 18300138
    [Abstract] [Full Text] [Related]

  • 23. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS.
    JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
    [Abstract] [Full Text] [Related]

  • 24. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial.
    Siegel EL, Rosenblum JD, Eckard DA, Leef J, Bergh J, Parsa MB, Redick ML.
    Acad Radiol; 1996 Sep; 3 Suppl 3():S507-13. PubMed ID: 8883529
    [Abstract] [Full Text] [Related]

  • 25. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
    Hardiek KJ, Katholi RE, Robbs RS, Katholi CE.
    J Diabetes Complications; 2008 Sep; 22(3):171-7. PubMed ID: 18413220
    [Abstract] [Full Text] [Related]

  • 26. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
    Schräder R, Esch I, Ensslen R, Fach WA, Merle H, Scherer D, Sievert H, Spies HF, Zeplin HE.
    J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
    [Abstract] [Full Text] [Related]

  • 27. Delayed side effects induced by iodinated contrast media, especially those associated with iodixanol.
    Idée JM, Corot C.
    Eur Radiol; 2003 Mar; 13(3):644-5; author reply 645. PubMed ID: 12659083
    [No Abstract] [Full Text] [Related]

  • 28. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography.
    Palmers Y, De Greef D, Grynne BH, Smits J, Put E.
    Eur J Radiol; 1993 Nov; 17(3):203-9. PubMed ID: 8293750
    [Abstract] [Full Text] [Related]

  • 29. [Iopromide, a new contrast medium for angiography. Clinical study and comparison with other low-osmolar contrast media].
    Steidle B, Wolf KJ, Banzer D, Seyferath W.
    Dtsch Med Wochenschr; 1984 Aug 24; 109(34):1275-8. PubMed ID: 6381018
    [Abstract] [Full Text] [Related]

  • 30. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate.
    Fransson SG, Stenport G, Andersson M.
    Acta Radiol; 1996 Mar 24; 37(2):218-22. PubMed ID: 8600966
    [Abstract] [Full Text] [Related]

  • 31. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
    Danzi GB, Capuano C, Sesana M, Predolini S, Baglini R.
    Catheter Cardiovasc Interv; 2003 Dec 24; 60(4):477-82. PubMed ID: 14624424
    [Abstract] [Full Text] [Related]

  • 32. Contrast media-induced ventricular fibrillation: an experimental study of the effects of dimeric contrast media during wedged catheter injection in dogs.
    Pedersen HK, Jacobsen EA, Refsum H.
    Acad Radiol; 1994 Oct 24; 1(2):136-44. PubMed ID: 9419477
    [Abstract] [Full Text] [Related]

  • 33. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
    Tveit K, Bolz KD, Bolstad B, Haugland T, Berg KJ, Skjaerpe T, Kloster YF.
    Acta Radiol; 1994 Nov 24; 35(6):614-8. PubMed ID: 7946687
    [Abstract] [Full Text] [Related]

  • 34. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P, Persson PB, Hansell P, Lagerqvist B.
    Kidney Int; 2006 Nov 24; 70(10):1811-7. PubMed ID: 17003814
    [Abstract] [Full Text] [Related]

  • 35. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
    Xiong HL, Peng M, Jiang XJ, Dong H, Che WQ, Chen Y, Zou YB, Xu B, Yang YJ, Gao RL.
    Int Urol Nephrol; 2018 Oct 24; 50(10):1879-1886. PubMed ID: 29948863
    [Abstract] [Full Text] [Related]

  • 36. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
    Schmid I, Didier D, Pfammatter T, Garachemani A, Fleisch M, Kirchin MA, Meier B.
    Int J Cardiol; 2007 Jun 12; 118(3):389-96. PubMed ID: 17376548
    [Abstract] [Full Text] [Related]

  • 37. Iodixanol in leg phlebography: a randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate.
    Sapoval MR, Beyssen BM, Girardot C, Musset MA, Legmann P, Brekke O, Gaux JC.
    Clin Radiol; 1996 Mar 12; 51(3):210-3. PubMed ID: 8605753
    [Abstract] [Full Text] [Related]

  • 38. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation.
    Barstad RM, Buchmann MS, Hamers MJ, Orning L, Orvim U, Stormorken H, Sakariassen KS.
    Acta Radiol; 1996 Nov 12; 37(6):954-61. PubMed ID: 8995473
    [Abstract] [Full Text] [Related]

  • 39. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study.
    Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF.
    Clin Radiol; 1993 Oct 12; 48(4):268-72. PubMed ID: 8243006
    [Abstract] [Full Text] [Related]

  • 40. Iomeprol: current and future profile of a radiocontrast agent.
    Katayama H, Spinazzi A, Fouillet X, Kirchin MA, Taroni P, Davies A.
    Invest Radiol; 2001 Feb 12; 36(2):87-96. PubMed ID: 11224756
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.